SomaLogic Announces Analyst and Investor Meeting on February 4, 2022

Rhea-AI Summary

On January 7, 2022, SomaLogic announced a virtual Analyst and Investor Meeting scheduled for February 4, 2022. This meeting will showcase the company's advancements in proteomics and its financial profile, aimed at outlining future growth plans. Additionally, company leadership will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022. Both events will be accessible via the company’s website. SomaLogic (Nasdaq: SLGC) focuses on delivering actionable health-management insights through personalized protein measurements.

Positive

• SomaLogic's participation in key events like the J.P. Morgan Healthcare Conference indicates strong industry engagement.
• The virtual Analyst and Investor Meeting aims to highlight the company's unique positioning in the proteomics space and its growth plans.

Negative

• None.

BOULDER, Colo., Jan. 07, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual Analyst and Investor Meeting on Friday, February 4, 2022, beginning at 10:00 a.m. Eastern Time. The virtual event will feature presentations from company leaders outlining SomaLogic’s unique positioning in proteomics, financial profile, and plans for continued business evolution and growth as the company furthers its scientific and commercial progress. The event will also feature a live panel with key opinion leaders and a Q&A session following speaker presentations.

SomaLogic management will also be presenting at the 40^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 a.m. Eastern Time.

A live and archived webcast of both events will be on the “Investors” section of the company’s website at https://investors.somalogic.com.

About SomaLogic
SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

The SomaScan Platform is for Research Use Only (RUO) and has not been cleared or approved by the U.S. Food and Drug Administration for diagnostic or patient management purposes.

SomaLogic Contact
Emilia Costales
720-798-5054
ecostales@somalogic.com

Investor Contact
Marissa Bych
Gilmartin Group LLC
investors@somalogic.com

FAQ

What is the date of the next Analyst and Investor Meeting for SomaLogic?

The next Analyst and Investor Meeting for SomaLogic is scheduled for February 4, 2022.

Where will SomaLogic present during the J.P. Morgan Healthcare Conference?

SomaLogic will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 8:15 a.m. Eastern Time.

What is the stock symbol for SomaLogic?

The stock symbol for SomaLogic is SLGC.

How can I access the webcasts of SomaLogic's events?

You can access the live and archived webcasts of SomaLogic's events on the 'Investors' section of their website.